2022-RA-1623-ESGO Effect of bevacizumab and complete cytoreductive surgery in advanced low grade serous ovarian cancer: a secondary analysis of MITO 22
L. Musacchio, M. Turinetto, M. Bartoletti, L. Arenare, D. Califano, V. Tuninetti, G. Cormio, C. Pisano, G. Valabrega, C. Marchetti, S. Cecere, S. Greggi, F. Raspagliesi, F. Perrone, A. Fagotti, D. Lorusso, G. Scambia, S. Pignata
{"title":"2022-RA-1623-ESGO Effect of bevacizumab and complete cytoreductive surgery in advanced low grade serous ovarian cancer: a secondary analysis of MITO 22","authors":"L. Musacchio, M. Turinetto, M. Bartoletti, L. Arenare, D. Califano, V. Tuninetti, G. Cormio, C. Pisano, G. Valabrega, C. Marchetti, S. Cecere, S. Greggi, F. Raspagliesi, F. Perrone, A. Fagotti, D. Lorusso, G. Scambia, S. Pignata","doi":"10.1136/ijgc-2022-esgo.759","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"25 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical ovarian cancer and other gynecologic malignancies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2022-esgo.759","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
